These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12530066)
1. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients. Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066 [TBL] [Abstract][Full Text] [Related]
2. FHIT gene in gastric cancer: association with tumour progression and prognosis. Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747 [TBL] [Abstract][Full Text] [Related]
3. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516 [TBL] [Abstract][Full Text] [Related]
4. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer. Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853 [TBL] [Abstract][Full Text] [Related]
5. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan. Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551 [TBL] [Abstract][Full Text] [Related]
7. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Ragnarsson G; Eiriksdottir G; Johannsdottir JT; Jonasson JG; Egilsson V; Ingvarsson S Br J Cancer; 1999 Mar; 79(9-10):1468-74. PubMed ID: 10188892 [TBL] [Abstract][Full Text] [Related]
9. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma]. Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189 [TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in lung hyperplastic lesions. Zhang JX; Shen H Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):313-7. PubMed ID: 12697461 [TBL] [Abstract][Full Text] [Related]
11. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
12. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients. Ismail HM; Medhat AM; Karim AM; Zakhary NI Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333 [TBL] [Abstract][Full Text] [Related]
13. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992 [TBL] [Abstract][Full Text] [Related]
14. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas. Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival. Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271 [TBL] [Abstract][Full Text] [Related]
16. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. Gray SE; Kay E; Leader M; Mabruk M J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825 [TBL] [Abstract][Full Text] [Related]
17. Fhit expression is absent or reduced in a subset of primary head and neck cancer. Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397 [TBL] [Abstract][Full Text] [Related]
18. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients. Pylkkanen L; Wolff H; Stjernvall T; Tuominen P; Sioris T; Karjalainen A; Anttila S; Husgafvel-Pursiainen K Int J Oncol; 2002 Feb; 20(2):285-90. PubMed ID: 11788890 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects. Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]